ICAD Stock

ICAD EV/EBIT

Delisted·Jul 16, 2025

The EV/EBIT (Enterprise Value to EBIT) of ICAD (ICAD) as of Jul 26, 2026 is -16.96. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -13.83 — a change of 22.67% (lower).

EV/EBIT

-16.96

YoY

22.67%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of ICAD is 2026 -16.96 . EV/EBIT (Enterprise Value to EBIT) of ICAD was 2025 -13.83 . It decreases by 22.67% lower compared to the previous year.

The ICAD EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
0.00 base
Jan 1, 2020
0.00 base
Jan 1, 2021
0.00 base
Jan 1, 2022
0.00 base
Jan 1, 2023
0.00 base
Jan 1, 2024
-7.69 base
Jan 1, 2025 (e)
-17.17 base
Jan 1, 2026 (e)
-27.59 base
YEARPRICE-TO-EBIT
2026 est -27.59
2025 est -17.17
2024 -7.69
2023 -
2022 -
2021 -
2020 -
2019 -
2018 -
2017 -
2016 -
2015 -
2014 -
2013 -
2012 -
2011 -
2010 -
2009 -
2008 -
2007 -
2006 -
2005 -
Access this data via the Eulerpool API

ICAD Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides ICAD's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates ICAD's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots ICAD's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if ICAD grows earnings faster than its peers.

ICAD Stock analysis

What does ICAD do? ICAD Inc is a leading company in medical imaging and automated image processing. It was founded in 1984 and is headquartered in Nashua, New Hampshire, USA. ICAD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICAD stock

EV/EBIT (Enterprise Value to EBIT) of ICAD is -16.96 in 2026.

Access this data via the Eulerpool API

Valuation — ICAD

All Key Metrics — ICAD